Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 0.3% – Time to Sell?

Finch Therapeutics Group, Inc. (NASDAQ:FNCH)’s stock price traded down 0.3% on Thursday . The stock traded as low as $14.05 and last traded at $15.75. 4,172 shares traded hands during mid-day trading, an increase of 69% from the average session volume of 2,467 shares. The stock had previously closed at $15.80.

Finch Therapeutics Group Trading Up 0.3 %

The company’s 50 day moving average price is $11.95 and its two-hundred day moving average price is $11.61. The stock has a market cap of $25.44 million, a P/E ratio of -1.79 and a beta of 1.30.

Finch Therapeutics Group Company Profile

Finch Therapeutics Group, Inc, a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates.